These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 37475499

  • 21. Phase I Study of the Pharmacodynamics and Safety of Sodium Zirconium Cyclosilicate in Healthy Chinese Adults.
    Cheung T, Sun F, Zhao J, Qin Y, Någård M.
    Clin Pharmacol Drug Dev; 2022 Mar; 11(3):348-357. PubMed ID: 34997825
    [Abstract] [Full Text] [Related]

  • 22. Management of hyperkalemia in chronic heart failure using sodium zirconium cyclosilicate.
    Oshima A, Imamura T, Narang N, Kinugawa K.
    Clin Cardiol; 2021 Sep; 44(9):1272-1275. PubMed ID: 34263946
    [Abstract] [Full Text] [Related]

  • 23. Effectiveness of Patiromer Versus Sodium Zirconium Cyclosilicate for the Management of Acute Hyperkalemia.
    Rydell A, Thackrey C, Molki M, Mullins BP.
    Ann Pharmacother; 2024 Aug; 58(8):790-795. PubMed ID: 37953506
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE.
    Roger SD, Spinowitz BS, Lerma EV, Singh B, Packham DK, Al-Shurbaji A, Kosiborod M.
    Am J Nephrol; 2019 Aug; 50(6):473-480. PubMed ID: 31658466
    [Abstract] [Full Text] [Related]

  • 25. Population Pharmacodynamic Dose-Response Analysis of Serum Potassium Following Dosing with Sodium Zirconium Cyclosilicate.
    Penland RC, Åstrand M, Boulton DW, Någård M.
    Clin Pharmacokinet; 2024 Apr; 63(4):551-560. PubMed ID: 38504082
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of sodium zirconium cyclosilicate in patients with baseline serum potassium level ≥ 5.5 mmol/L: pooled analysis from two phase 3 trials.
    Amin AN, Menoyo J, Singh B, Kim CS.
    BMC Nephrol; 2019 Dec 02; 20(1):440. PubMed ID: 31791288
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Potassium-lowering effects of sodium zirconium cyclosilicate in the early post-transplant period.
    Shockey W, Wiegel JJ, Parajuli S, Garg N, Swanson KJ, Mandelbrot DA.
    Clin Transplant; 2024 Jan 02; 38(1):e15156. PubMed ID: 37812572
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Sodium zirconium cyclosilicate for the management of chronic hyperkalemia in kidney disease, a novel agent.
    Rastogi A, Hanna RM, Mkrttchyan A, Khalid M, Yaqoob S, Shaffer K, Dhawan P, Nobakht N, Kamgar M, Goshtaseb R, Sarmosyan K, Gnarini M, Wassef O, Lerma E.
    Expert Rev Clin Pharmacol; 2021 Sep 02; 14(9):1055-1064. PubMed ID: 34227913
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Potassium binders for chronic hyperkalaemia in people with chronic kidney disease.
    Natale P, Palmer SC, Ruospo M, Saglimbene VM, Strippoli GF.
    Cochrane Database Syst Rev; 2020 Jun 26; 6(6):CD013165. PubMed ID: 32588430
    [Abstract] [Full Text] [Related]

  • 36. Effects of Patiromer and Sodium Zirconium Cyclosilicate on Blood Pressure in Rats with Chronic Kidney Disease.
    Li L, Budden J, Quinn CM, Bushinsky D.
    J Cardiovasc Pharmacol Ther; 2024 Jun 26; 29():10742484241227580. PubMed ID: 38311939
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cost-effectiveness analysis of sodium zirconium cyclosilicate for hyperkalemia among patients with chronic kidney disease or heart failure in Kuwait.
    Elsisi GH, Mahmoud MMI, Al-Humood K, Al-Yousef A.
    J Med Econ; 2024 Jun 26; 27(1):253-265. PubMed ID: 38318718
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.